Literature DB >> 15322168

Functional maturation of CD4+CD25+CTLA4+CD45RA+ T regulatory cells in human neonatal T cell responses to environmental antigens/allergens.

Catherine A Thornton1, John W Upham, Matthew E Wikström, Barbara J Holt, Gregory P White, Mary J Sharp, Peter D Sly, Patrick G Holt.   

Abstract

A number of laboratories have reported cord blood T cell responses to ubiquitous environmental Ags, including allergens, by proliferation and cytokine secretion. Moreover, the magnitude of these responses has been linked with risk for subsequent expression of allergy. These findings have been widely interpreted as evidence for transplacental priming and the development of fetal T memory cells against Ags present in the maternal environment. However, we present findings below that suggest that neonatal T cell responses to allergens (and other Ags) differ markedly from those occurring in later life. Notably, in contrast to allergen-responsive adult CD4(+) T cell cultures, responding neonatal T cell cultures display high levels of apoptosis. Comparable responses were observed against a range of microbial Ags and against a parasite Ag absent from the local environment, but not against autoantigen. A notable finding was the appearance in these cultures of CD4(+)CD25(+)CTLA4(+) T cells that de novo develop MLR-suppressive activity. These cells moreover expressed CD45RA and CD38, hallmarks of recent thymic emigrants. CFSE-labeling studies indicate that the CD4(+)CD25(+) cells observed at the end of the culture period were present in the day 0 starting populations, but they were not suppressive in MLR responses. Collectively, these findings suggest that a significant component of the reactivity of human neonatal CD4(+) T cells toward nominal Ag (allergen) represents a default response by recent thymic emigrants, providing an initial burst of short-lived cellular immunity in the absence of conventional T cell memory, which is limited in intensity and duration via the parallel activation of regulatory T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322168     DOI: 10.4049/jimmunol.173.5.3084

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Associations of cord blood fatty acids with lymphocyte proliferation, IL-13, and IFN-gamma.

Authors:  Diane R Gold; Ben M Willwerth; Kelan G Tantisira; Patricia W Finn; Bianca Schaub; David L Perkins; Arthur Tzianabos; Ngoc P Ly; Christian Schroeter; Fiona Gibbons; Hannia Campos; Emily Oken; Matthew W Gillman; Lyle J Palmer; Louise M Ryan; Scott T Weiss
Journal:  J Allergy Clin Immunol       Date:  2006-02-14       Impact factor: 10.793

2.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: neonatal immune function and vaccine responses in children born in low-income versus high-income countries.

Authors:  A H J van den Biggelaar; P G Holt
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 3.  Does early feeding promote development of oral tolerance?

Authors:  Debra J Palmer; Susan L Prescott
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

4.  Genistein enhancement of respiratory allergen trimellitic anhydride-induced IgE production by adult B6C3F1 mice following in utero and postnatal exposure.

Authors:  Tai L Guo; W Auttachoat; Rui P Chi
Journal:  Toxicol Sci       Date:  2005-07-27       Impact factor: 4.849

Review 5.  Defective antigen-presenting cell function in human neonates.

Authors:  Paula A Velilla; Maria T Rugeles; Claire A Chougnet
Journal:  Clin Immunol       Date:  2006-09-28       Impact factor: 3.969

6.  Antigen-specific immune responses to influenza vaccine in utero.

Authors:  Deepa Rastogi; Chaodong Wang; Xia Mao; Cynthia Lendor; Paul B Rothman; Rachel L Miller
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

Review 7.  T and B cell responses to HDM allergens and antigens.

Authors:  Wayne R Thomas; Belinda J Hales
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

Authors:  Patrick J Hanley; Conrad Russell Young Cruz; Barbara Savoldo; Ann M Leen; Maja Stanojevic; Mariam Khalil; William Decker; Jeffrey J Molldrem; Hao Liu; Adrian P Gee; Cliona M Rooney; Helen E Heslop; Gianpietro Dotti; Malcolm K Brenner; Elizabeth J Shpall; Catherine M Bollard
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

9.  Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.

Authors:  Alana A Kennedy-Nasser; Stephanie Ku; Paul Castillo-Caro; Yasmin Hazrat; Meng-Fen Wu; Hao Liu; Jos Melenhorst; A John Barrett; Sawa Ito; Aaron Foster; Barbara Savoldo; Eric Yvon; George Carrum; Carlos A Ramos; Robert A Krance; Kathryn Leung; Helen E Heslop; Malcolm K Brenner; Catherine M Bollard
Journal:  Clin Cancer Res       Date:  2014-02-26       Impact factor: 12.531

10.  Cytomegalovirus upregulates expression of CCR5 in central memory cord blood mononuclear cells, which may facilitate in utero HIV type 1 transmission.

Authors:  Erica L Johnson; Chanie L Howard; Joy Thurman; Kyle Pontiff; Elan S Johnson; Rana Chakraborty
Journal:  J Infect Dis       Date:  2014-07-31       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.